Literature DB >> 8392317

The regulation by light of retinal necrosis and the immune response following anterior chamber inoculation of herpes simplex virus type-1.

M Kahn1, H J Kaplan, T A Ferguson.   

Abstract

Following anterior chamber injection of the KOS strain of herpes simplex virus type 1 into Balb/c mice a characteristic pathologic response occurs. When examined 10-14 days later there is intense anterior segment inflammation of the injected eye, but the retina is spared. In contrast, the contralateral eye undergoes intense and destructive retinitis with little or no involvement of the anterior segment. Coincident with these observations is the induction of ACAID (for anterior chamber associated immune deviation) which is characterized by a suppressed DTH response, normal antibody titers, and normal cytolytic T-cell responses to HSV antigens. Since we have recently demonstrated that ACAID does not take place in the absence of light (i.e., is light dependent), we have examined the effect of light on the HSV-retinitis model. When Balb/c mice are either dark-reared or dark-adapted prior to AC injection of HSV-1, contralateral retinitis is abolished. Concurrent with the abrogation of retinitis, is the elimination of ACAID to HSV-1 antigens. In addition, although contralateral retinitis and ACAID do not develop in dark-reared mice if they are placed in the light immediately following injection, both can be re-established in dark-reared animals following a 2 week period of re-adaptation to light. Our results demonstrate that the entrance of light into the eye is not only important for ACAID, but also for the development of contralateral HSV-induced retinitis.

Entities:  

Mesh:

Year:  1993        PMID: 8392317     DOI: 10.1007/bf01379084

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  15 in total

1.  Two waves of virus following anterior chamber inoculation of HSV-1.

Authors:  S S Atherton; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-03       Impact factor: 4.799

2.  The immune response and the eye. III. Anterior chamber-associated immune deviation can be adoptively transferred by serum.

Authors:  T A Ferguson; J D Hayashi; H J Kaplan
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

3.  The immune response and the eye. II. The nature of T suppressor cell induction in anterior chamber-associated immune deviation (ACAID).

Authors:  T A Ferguson; J C Waldrep; H J Kaplan
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

Review 4.  Postnatal development of the visual cortex and the influence of environment.

Authors:  T N Wiesel
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

5.  Retinitis and deviant immune responses following intravitreal inoculation of HSV-1.

Authors:  S S Atherton; G A Pesicka; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-05       Impact factor: 4.799

6.  Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.

Authors:  R Hemady; J Tauber; T M Ihley; E M Opremcak; C S Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-11       Impact factor: 4.799

7.  Herpes simplex virus type 1. A cause of the acute retinal necrosis syndrome.

Authors:  M L Lewis; W W Culbertson; J D Post; D Miller; G T Kokame; R D Dix
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

8.  Ocular immune responses. I. Priming of A/J mice in the anterior chamber with azobenzenearsonate-derivatized cells induces second-order-like suppressor T cells.

Authors:  R P Wetzig; C S Foster; M I Greene
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

9.  Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus.

Authors:  J A Whittum; J P McCulley; J Y Niederkorn; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-09       Impact factor: 4.799

10.  Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.

Authors:  J Niederkorn; J W Streilein; J A Shadduck
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.